Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-05-13 @ 5:08 PM
Study NCT ID:
NCT06280495
Status:
RECRUITING
Last Update Posted:
2025-05-30
First Post:
2024-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Sponsor:
Organization: